TITLE:
Etanercept (Enbrel) in Psoriasis - Pediatrics

CONDITION:
Psoriasis

INTERVENTION:
Enbrel

SUMMARY:

      This study will evaluate the safety and efficacy of etanercept (Enbrel) in children with
      Psoriasis.

      This is a Phase 3 blinded, placebo-controlled study.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 4 Years to 17 Years
Criteria:

        -  Patients with plaque psoriasis - Patient may not receive certain psoriasis
             medications during the study
      
